Mark M. Fuster
Impact in
- Cell Biology top 1%
- Proteoglycans and glycosaminoglycans research
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Papers in
-
- Glycosylation and Glycoproteins Research 12
- Angiogenesis and VEGF in Cancer 5
-
- Lung Cancer Diagnosis and Treatment 9
- Co-authors
- Jeffrey D. Esko (12 shared papers)Lianchun Wang (6 shared papers)P. Sriramarao (4 shared papers)Jillian R. Brown (6 shared papers)Roger Lawrence (4 shared papers)Manuela Schuksz (4 shared papers)Andrew L. Ries (7 shared papers)Duc Ha (7 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Neoplasia (3 papers)Clinical Lung Cancer (3 papers)Proceedings of the National Academy of Sciences (2 papers)Biophysical Journal (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Mark M. Fuster
49 papers receiving 3.1k citations
Mark M. Fuster's Hit Papers
Peers
Comparison fields: 5 of 115
- Cell Biology 910
- Immunology and Allergy 205
- Immunology 587
- Molecular Biology 1.8k
- Organic Chemistry 561
Countries citing papers authored by Mark M. Fuster
This map shows the geographic impact of Mark M. Fuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Fuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Fuster more than expected).
Fields of papers citing papers by Mark M. Fuster
This network shows the impact of papers produced by Mark M. Fuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Fuster. The network helps show where Mark M. Fuster may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark M. Fuster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The sweet and sour of cancer: glycans as novel therapeutic targets Hit paper breakdown → | 2005 | 1153 |
| 2 | 2005 | 398 | |
| 3 | 2020 | 234 | |
| 4 | 2008 | 144 | |
| 5 | 2001 | 103 | |
| 6 | 2007 | 96 | |
| 7 | A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. | 2003 | 92 |
| 8 | 2016 | 86 | |
| 9 | 2010 | 80 | |
| 10 | 2010 | 73 | |
| 11 | 2016 | 58 | |
| 12 | 2011 | 46 | |
| 13 | 2006 | 43 | |
| 14 | 2016 | 42 | |
| 15 | 2009 | 40 | |
| 16 | 2003 | 38 | |
| 17 | 2013 | 36 | |
| 18 | 2010 | 29 | |
| 19 | 2016 | 28 | |
| 20 | 2020 | 27 |
About Mark M. Fuster
Mark M. Fuster is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cell Biology, Oncology and Immunology, having authored 49 papers that have together received 3.1k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (14 papers), Glycosylation and Glycoproteins Research (12 papers), Lung Cancer Diagnosis and Treatment (9 papers), Lymphatic System and Diseases (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Carbohydrate Chemistry and Synthesis (4 papers), Immunotherapy and Immune Responses (4 papers) and Cancer survivorship and care (4 papers). The work is most often cited by research in Cell Biology (910 citations), Immunology and Allergy (205 citations), Immunology (587 citations), Molecular Biology (1.8k citations) and Organic Chemistry (561 citations). Mark M. Fuster has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Jeffrey D. Esko, Lianchun Wang, P. Sriramarao, Jillian R. Brown, Roger Lawrence, Manuela Schuksz, Andrew L. Ries, Duc Ha, Charles A. Glass and Ding Xu. Their work appears in journals such as Journal of Biological Chemistry, Neoplasia, Clinical Lung Cancer, Proceedings of the National Academy of Sciences and Biophysical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.